Miami, FLNCT05550298Now EnrollingIRB Ready

Hematopoietic Cell Transplant Clinical Trial in Miami, FL

Access cutting-edge hematopoietic cell transplant treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by Arkansas Children's Hospital Research Institute

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions…

Expert Care in Miami

Access hematopoietic cell transplant specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hematopoietic cell transplant treatment provided free

Apply for This Miami Location

Check if you qualify for this hematopoietic cell transplant clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Hematopoietic Cell Transplant Study in Miami

The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: * To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. * To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .

Sponsor: Arkansas Children's Hospital Research Institute

Who Can Participate

Inclusion Criteria

Less than 18 years at the time of anticipated transplant
Participant meets one of the following criteria:
scheduled to receive allogeneic hematopoietic cell transplant within 14 days of enrollment or
Scheduled to or received solid organ transplant within 7 days before or after enrollment
Participant is receiving care at the time of enrollment at one of the study participating institutions.
Parent/guardian willing and able to provide informed consent, and if appropriate, child willing and able to provide informed assent. Donor Inclusion Criteria
Donor for HCT recipient enrolled on the VIPER study.
Willing and able to provide informed consent.

Exclusion Criteria

Recipient Exclusion Criteria None Donor Exclusion Criteria
Is not an HCT donor for a participant enrolled on the VIPER study.
Not available to provide pre-transplant research blood sample.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT05550298) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hematopoietic Cell Transplant Treatment Options in Miami, FL

If you're searching for hematopoietic cell transplant treatment options in Miami, FL, this clinical trial (NCT05550298) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hematopoietic cell transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hematopoietic cell transplant clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Miami, FL

See all essential tremor clinical trials recruiting in Miami — not just this study.

Browse Essential Tremor Trials in Miami

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL